How to Value Cannabis Stocks: P/S, EV/Revenue

The cannabis industry presents unique valuation challenges. Most cannabis companies are not profitable — some due to genuine business issues, others due to the Section 280E tax burden that inflates effective tax rates to 60-80%. Traditional valuation metrics like P/E ratios are useless when earnings are negative.

Instead, cannabis investors rely on revenue-based metrics (P/S, EV/Revenue), margin analysis (gross margin as a profitability proxy), and cash flow analysis (cash burn rate and runway). Understanding these metrics — and their limitations — is essential for making informed investment decisions in the cannabis sector.

The data below is generated from Cannabismarketcap's live database of 100 cannabis companies. The current median P/S ratio across all cannabis stocks with revenue is 2.27x.

The Price-to-Sales ratio is calculated by dividing a company's market capitalization by its trailing twelve-month revenue. It answers the question: "How much am I paying for each dollar of revenue this company generates?"

Formula: P/S = Market Cap / Revenue TTM

A P/S of 2.0x means investors are paying $2 for every $1 of annual revenue. In the cannabis sector, P/S ratios typically range from 0.3x to 5x, with the median at 2.27x. Companies trading well below the median may be undervalued — or may have fundamental problems that justify the discount.

Limitations of P/S: P/S does not account for profitability, debt, or cash position. A company with $100M in revenue but $200M in debt and negative margins is not necessarily "cheap" at a P/S of 0.5x. Always pair P/S analysis with margin and balance sheet evaluation.

Enterprise Value to Revenue is a more comprehensive metric than P/S because it accounts for a company's capital structure — specifically its debt and cash positions.

Formula: EV = Market Cap + Total Debt - Cash on Hand
EV/Revenue = Enterprise Value / Revenue TTM

This matters significantly in cannabis because many companies carry substantial debt. Consider two companies, both with $500M market cap and $200M revenue (P/S = 2.5x):

Company A: $50M debt, $100M cash → EV = $450M → EV/Rev = 2.25x
Company B: $300M debt, $20M cash → EV = $780M → EV/Rev = 3.90x

Company B is significantly more expensive on an EV/Revenue basis despite the same P/S ratio. The debt-adjusted view reveals the true cost of acquiring the company's revenue stream. Among cannabis stocks tracked by Cannabismarketcap, 0 companies have calculable EV/Revenue ratios.

Gross margin measures what percentage of revenue remains after subtracting the direct cost of producing goods. In cannabis, this includes cultivation costs, extraction, manufacturing, and packaging.

Formula: Gross Margin = (Revenue - Cost of Goods Sold) / Revenue

Cannabis gross margins vary widely by business model. Vertically integrated US MSOs (growing, processing, and retailing) often achieve 45-55% gross margins. Canadian LPs in the competitive wholesale market may see 25-40%. Ancillary companies (technology, services) that don't touch the plant can achieve 60%+ margins.

Among the top 5 cannabis companies by gross margin on Cannabismarketcap:

Cash burn analysis answers the question: "How long can this company survive without raising additional capital?" This is critical in cannabis, where many companies are operating at a loss and periodically need to raise capital through dilutive equity offerings or expensive debt.

Cash Burn Rate: Monthly or quarterly cash consumed by operations. Calculated from operating cash flow (negative operating cash flow = cash burn).

Cash Runway: Cash on Hand divided by Monthly Burn Rate = Months of Runway. Companies with fewer than 12 months of runway are in a precarious position. Those with fewer than 6 months will almost certainly need to raise capital imminently.

When a company with a low stock price raises capital, it often does so through deeply discounted share offerings, convertible notes, or warrant packages — all of which severely dilute existing shareholders. This creates a vicious cycle: low price → dilutive financing → more shares outstanding → lower price per share → more dilution needed.

Use the cash burn rankings to compare runway across all cannabis companies.

The following cannabis stocks have the lowest Price-to-Sales ratios, which may indicate undervaluation. However, a low P/S can also reflect legitimate concerns about the company's growth prospects, balance sheet, or competitive position. Always conduct further research before making investment decisions.

These cannabis stocks have the highest Price-to-Sales ratios. A high P/S is not necessarily bad — it may reflect strong growth expectations, premium brand value, or strategic positioning. But it does mean the market is pricing in significant future performance that the company must deliver to justify current prices.

Let us walk through two real examples from the Cannabismarketcap database:

Example 1: Hydrofarm Holdings (HYFM)
Market Cap: $5.6M
Revenue TTM: $146.4M
P/S Ratio: 0.04x
EV/Revenue: —
Gross Margin: 11.6%
At a P/S of 0.04x, this is one of the lowest-valued cannabis stocks by this metric. The question for investors: is this cheap for a reason, or is the market mispricing the revenue stream?

Example 2: Akerna Corp (KERN)
Market Cap: $376.3M
Revenue TTM: $6.8M
P/S Ratio: 55.05x
EV/Revenue: —
Gross Margin: 402.0%
At a P/S of 55.05x, the market is pricing in substantial future growth. Investors need to assess whether the growth trajectory justifies this premium valuation.